Eye2Gene Company Profile: Funding, Investors & Partnerships

Eye2Gene

Eye2Gene, a UCL/Moorfield Eye Hospital spinout, is the first AI-powered precision ophthalmology platform integrating multimodal retinal imaging and genetics to accelerate clinical trials, initially for Inherited Retinal Diseases(IRD). Our software helps pharma partners identify genetically stratified cohorts, cut screen failures, and replace slow, costly manual image analysis with automated quantitative imaging biomarkers delivered in seconds, speeding trial execution and monitoring.Eye2Gene, a UCL/Moorfield Eye Hospital spinout, is the first AI-powered precision ophthalmology plat Show More

Alpha Score

36.3